Fujian Wanchen Biotechnology Group Co., Ltd.'s (SZSE:300972) Subdued P/S Might Signal An Opportunity
Be Wary Of Fujian Wanchen Biotechnology Group (SZSE:300972) And Its Returns On Capital
Snack discount leader's profit inflection point has arrived | Insight Research
Wanchen Group's net profit for the third quarter was positive, and the net interest rate increased for four consecutive quarters.
Wanchen Group (300972.SZ) announced first-quarter results, net profit of 6.2382 million yuan, a decrease of 88.15%
According to the Zhitong Finance App, Wanchen Group (300972.SZ) released its report for the first quarter of 2024. The company's revenue was 4.83 billion yuan, an increase of 534.03% over the previous year. Net profit attributable to shareholders of listed companies was 6.2382 million yuan, a year-on-year decrease of 88.15%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1.98,800 yuan, a year-on-year decrease of 96.17%. Basic earnings per share were $0.0388.
Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Wanchen Group (300972.SZ) announced its 2023 annual results, changing profit to loss to 82.965 million yuan
Wanchen Group (300972.SZ) released its 2023 annual report. The company's revenue was 9.294 billion...
Wanchen Group (300972.SZ) will list and circulate 786.84 million restricted shares on April 23
Wanchen Group (300972.SZ) announced that the number of shares issued before the company's initial public offering has lifted sales restrictions this time...
Wanchen Group (300972.SZ) performance report: 2023 net loss of 82.965 million yuan
Gelonghui, April 15, 丨 Wanchen Group (300972.SZ) announced its 2023 annual performance report, with total operating revenue of 9.294 billion yuan, up 1,592.03% over the same period of the previous year; total profit - 84718,700 yuan, down 303.76% from the same period of the previous year; net profit attributable to shareholders of listed companies - 82.92.65 million yuan, year-on-year profit and loss; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 83.7569 million yuan; basic earnings per share - 0.5395 yuan.
Wanchen Group (300972.SZ) plans to promote 11.329 million restricted stock incentive plans
According to the Zhitong Finance App, Wanchen Group (300972.SZ) disclosed the 2024 Restricted Stock Incentive Plan (draft). The number of restricted shares to be awarded by the company's incentive plan is 11.329 million shares, accounting for 6.57% of the company's total share capital of 172.3932 million shares on the day the draft incentive plan was announced. Among them, the number of restricted shares granted for the first time was 10.129 million shares, and the number of restricted shares reserved was 1.2 million shares, and the grant price was 15.17 yuan/share. A total of 58 people were awarded incentives for the first time under this incentive plan.
Potential Upside For Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Not Without Risk
Private Companies Among Fujian Wanchen Biotechnology Group Co., Ltd.'s (SZSE:300972) Largest Stockholders and Were Hit After Last Week's 12% Price Drop
Wanchen Group (300972.SZ): The current number of SKUs is 1500~1,800
Gelonghui, January 25丨Wanchen Group (300972.SZ) recently said during a survey from institutional investors that we have always maintained a relatively fast monthly SKU iteration frequency. In order to achieve this goal, we try to introduce as many products that are not in the same category as possible, rather than just updating products. Currently, our number of SKUs is 1500 to 1,800, which accounts for a relatively low number of snack foods, and there is still plenty of room to continuously expand and iterate on new products. The company will not create its own brand in order to have its own brand. The core indicator of our product selection is whether this product is this segment
Wanchen Group (300972.SZ): Currently, the company is a leading enterprise in the mass sales of snacks
Gelonghui, January 25丨Wanchen Group (300972.SZ) recently said during a survey reception from institutional investors that we are firmly optimistic about the future growth prospects of the mass snack industry. The overall mass sales business is still not high in terms of store density across the country. At present, the company is already a leading enterprise in the mass sales of snacks, and in many regional markets, we have obvious advantages in terms of business scale, consumer recognition, franchise ecology, and brand mentality. In the future, the company will continue to cultivate the existing advantageous regions, and maintain rapid growth potential in other markets to serve our consumers well.
Wanchen Group (300972.SZ): Pre-loss of 69 million yuan to 89 million yuan in 2023
Gelonghui, January 19, 丨 Wanchen Group (300972.SZ) announced its 2023 annual results forecast. Net profit loss attributable to shareholders of listed companies during the reporting period was 89 million yuan to 69 million yuan, with profit of 47.6656 million yuan for the same period last year; net profit loss attributable to shareholders of listed companies after deducting non-recurring profit and loss was 89.4 million yuan to 69.4 million yuan, a profit of 33.0947 million yuan for the same period last year; operating income of 900,000 yuan to 960,000 yuan. During the reporting period, thanks to the expansion of the scale of the mass snack sales business, the company's revenue is expected to compare
Cinda Securities: Starting an era dominated by demand, mass snack sales are on the rise
The Zhitong Finance App learned that Cinda Securities released a research report saying that if you look back at the history of retail development in foreign countries, you will find that the discount business is usually born in the context of a slowdown in macroeconomic growth. For example, Aldi, the originator of discounts, was born during the German economic depression period after World War II, and Don Quixote and Uniqlo all rose after Japan's economic bubble burst. In the context of changes in domestic retail channels and consumers becoming more rational and mature, domestic consumption is shifting from supply-driven to a demand-led era, focusing on investment opportunities to improve channel efficiency and investment opportunities for manufacturers that actively embrace new channels, high supply chain efficiency, and innovative products.
Wanchen Group (300972.SZ)'s application for a fixed increase in shares was approved for registration by the China Securities Regulatory Commission
Wanchen Group (300972.SZ) announced that the company recently received the “On...” issued by the China Securities Regulatory Commission
Wanchen Group (300972.SZ): Currently, it has high brand awareness in the South China and East China markets, and is gradually expanding to Central China, North China, Southwest China and other regions
Gelonghui, December 15, Wanchen Group (300972.SZ) stated on the investor interactive platform that at present, the company's products are mainly sold to East China, South China, and Central China, and also cover southwest China, northwest China, North China and Northeast China. Through good product quality and stable supply, the company's products have established a good reputation in the market. Different companies have different brand advantages in different markets. Currently, the company has high brand awareness in the South China and East China markets, and has gradually expanded to Central China, North China, Southwest China and other regions.
Cinda Securities: The end of the three-quarter report is expected to enter a rebound window, and the probability of a monthly rebound of more than a month is very high (with the top ten gold stocks in November)
There is a high probability that the market will rebound more than a month. At the same time, as the disclosure of the three-quarter report nears its end, the stock market is expected to enter a window period conducive to a rebound.
Fujian Wanchen Biotechnology Group Co., Ltd.'s (SZSE:300972) Largest Shareholders Are Private Companies Who Were Rewarded as Market Cap Surged CN¥496m Last Week
[Instant Analysis of BT Financial Report] Wan Chen Group's 2023 Third Quarter Report: Balance Ratio Rises, Net Profit Turns Negative, Net Cash Flow Decreased
Announcement time of this financial report: 2023-10-24 13:20:41 Fujian Wanchen Biotechnology Group Co., Ltd. (stock code: 300972), referred to as Wanchen Group for short, is an enterprise focusing on R&D, factory cultivation and sales of fresh edible fungi. Relying on modern biotechnology, the company uses factory methods to produce edible fungi, and is committed to providing consumers with “green, environmentally friendly, safe and high-quality” edible fungus products. In terms of assets and liabilities, at the end of the third quarter of 2023, Wan Chen Group's total assets reached 2,529 billion yuan, compared to 1.01 billion yuan at the end of the previous year
No Data